Fundraising Fox
/Companies
Sign in

AssayQuant Technologies

Marlboro, US · Delaware corporation

Find your way into AssayQuant Technologies

Sign up to see every warm intro you have to AssayQuant Technologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AssayQuant Technologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AssayQuant develops PhosphoSens fluorescent sensor peptide substrates and assay kits that measure kinase and phosphatase activity in real time, along with KinSight lab services for compound potency, selectivity, and mechanism-of-inhibition profiling. Its products and services serve preclinical drug discovery teams working on kinase and phosphatase inhibitors, covering over 500 kinase and 35 phosphatase targets.</parameter> <parameter name="sector_codes">["biotech", "deeptech"]

Biotech

Founders & leadership

ESErik Schaefer
Erik SchaeferCo-founder & CSOErik Schaefer is an Executive Officer at AssayQuant Technologies with more than 25 years in life sciences research tools, including experience in technology development, product commercialization, and cross-functional leadership across engineering, biology, and assay development. His work has focused on kinase and phosphatase research and drug discovery applications.
BI
Barbara ImperialiNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.6M disclosed across 2 rounds · 2021–2023

▶$5.1MraisedJul 2023 · 21 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Barbara ImperialiDirector
  • Gil PriceDirector
  • Jeffrey HoerleDirector
  • Erik SchaeferExecutive Officer
  • Charles BalticDirector
Offering amount
$12M
Amount sold
$5.1M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$4.5MraisedMay 2021 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Erik SchaeferExecutive Officer
  • Barbara ImperialiDirector
Offering amount
$4.5M
Amount sold
$4.5M
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

BellBrook LabsBellBrook Labs supplies life-science research products and services to laboratories, distributed internationally through regional partners across Europe, Asia, and Oceania. Its offerings serve the biotechnology and drug-discovery research market.
RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.

Companies working in the same space as AssayQuant Technologies.

Frequently asked questions

What does AssayQuant Technologies do?
AssayQuant develops PhosphoSens fluorescent sensor peptide substrates and assay kits that measure kinase and phosphatase activity in real time, along with KinSight lab services for compound potency, selectivity, and mechanism-of-inhibition profiling. Its products and services serve preclinical drug discovery teams working on kinase and phosphatase inhibitors, covering over 500 kinase and 35 phosphatase targets.</parameter> <parameter name="sector_codes">["biotech", "deeptech"]
Who founded AssayQuant Technologies?
AssayQuant Technologies was founded by Erik Schaefer.
How much funding has AssayQuant Technologies raised?
AssayQuant Technologies has disclosed $9.6M raised across 2 rounds.
Where is AssayQuant Technologies headquartered?
AssayQuant Technologies is headquartered in Marlboro, US.